Journal article
Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy
Annapurna Poduri, Sameer S Chopra, Edward G Neilan, P Christina Elhosary, Manju A Kurian, Esther Meyer, Brenda J Barry, Omar S Khwaja, Mustafa AM Salih, Tommy Stoedberg, Ingrid E Scheffer, Eamonn R Maher, Mustafa Sahin, Bai-Lin Wu, Gerard T Berry, Christopher A Walsh, Jonathan Picker, Sanjeev V Kothare
Epilepsia | WILEY-BLACKWELL | Published : 2012
Grants
Awarded by NINDS
Awarded by College of Medicine Research Center (CMRC)
Awarded by Chinese National "973" project on Population and Health
Awarded by Science and Technology Council of Shanghai
Awarded by NIMH
Awarded by Novartis
Awarded by Action Medical Research
Awarded by Great Ormond Street Hospital Childrens Charity
Awarded by NATIONAL INSTITUTE OF MENTAL HEALTH
Awarded by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Funding Acknowledgements
We thank the families of the children with MMPEI who participated in this research study. Annapurna Poduri was supported by the NINDS (K23NS069784). Manju Kurian's research is funded by Action Medical Research and Great Ormond Street Children's Charities. Mustafa A. Salih was supported by the College of Medicine Research Center (CMRC Project No. 07-581), College of Medicine, King Saud University, Riyadh, Saudi Arabia. Mustafa Sahin is an investigator of the CHB Translational Research Program and was also supported by John Merck Fund, Nancy Lurie Marks Family Foundation, and Manton Center for Orphan Disease Research. Ingrid E. Scheffer receives/has received research support from the National Health and Medical Research Council of Australia, Health Research Council of New Zealand, The University of Melbourne, American Epilepsy Society, the Jack Brockhoff Foundation, the Shepherd Foundation and the Perpetual Charitable Trustees. Eamonn Maher's research was funded by Action Medical Research. Bai-Lin Wu is supported by the Chinese National "973" project on Population and Health (2010CB529601) and the Science and Technology Council of Shanghai (09JC1402400). Christopher A. Walsh is an investigator of the Howard Hughes Medical Institute and was also supported by the NINDS (R01NS035129, R01NS035129S), the NIMH (NIMH1RC2MH089952), the Manton Center for Orphan Disease Research, the Dubai Harvard Foundation for Medical Research, the Simons Foundation, and the Nancy Lurie Marks Family Foundation.Dr. Neilan was supported by Pharming Group and the Luke O'Brien Foundation. Dr. Scheffer has served on scientific advisory boards for UCB and Janssen-Cilag EMEA, received speaker honoraria from Athena Diagnostics, UCB, Biocodex and Janssen-Cilag EMEA, and received funding for travel from Athena Diagnostics, UCB, Biocodex, and Janssen-Cilag EMEA. Dr. Sahin's research has been supported by Novartis (NCT00789828). The other authors report no disclosures. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.